Newbridge Financial Services Group’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-300
Closed -$2.83K 1326
2025
Q1
$2.83K Hold
300
﹤0.01% 860
2024
Q4
$3.69K Hold
300
﹤0.01% 901
2024
Q3
$4.49K Hold
300
﹤0.01% 513
2024
Q2
$4.05K Buy
+300
New +$4.05K ﹤0.01% 876